MRC1 and glioblastoma: Our data showed that pretreatment of human GBM ECs with harmine in vitro inhibited EC-induced M2-like Mφ phenotypes in a dose-dependent manner, as indicated by reduced CD206 and IL-10 expressions in harmine-treated Mφs (Fig. 4, A and B).